Healthcare ❯Pharmaceuticals ❯Clinical Trials

Drug Development

Weight Loss Treatment Elinzanetant Eli Lilly Azelaprag Vibozilimod

SPARC Shares Plunge Nearly 20% After Failed Phase 2 Vibozilimod Trials

Halting atopic dermatitis trials, Sun Pharma is collaborating with SPARC on new development plans following Vibozilimod’s failure to meet primary endpoints.

3 ARTICLES

11mo ago

New Non-Hormonal Drug Shows Promise for Menopausal Hot Flashes

5 ARTICLES

last yr.

Alnylam's Heart Drug Shows Promising Phase-3 Results, Boosting Stock